NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.030
-0.020 (-1.90%)
Mar 20, 2026, 4:00 PM EDT - Market closed
NanoViricides Market Cap
NanoViricides has a market cap or net worth of $22.24 million as of March 20, 2026. Its market cap has increased by 7.98% in one year.
Market Cap
22.24M
Enterprise Value
17.09M
1-Year Change
7.98%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since September 25, 2013, NanoViricides's market cap has decreased from $293.90M to $22.24M, a decrease of -92.43%. That is a compound annual growth rate of -18.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 22.20M | 9.36% |
| Dec 31, 2025 | 20.30M | -0.98% |
| Dec 31, 2024 | 20.50M | 70.83% |
| Dec 29, 2023 | 12.00M | -6.98% |
| Dec 30, 2022 | 12.90M | -69.93% |
| Dec 31, 2021 | 42.90M | 40.20% |
| Dec 31, 2020 | 30.60M | 215.46% |
| Dec 31, 2019 | 9.70M | -30.22% |
| Dec 31, 2018 | 13.90M | -75.04% |
| Dec 29, 2017 | 55.70M | -10.59% |
| Dec 30, 2016 | 62.30M | -8.38% |
| Dec 31, 2015 | 68.00M | -56.21% |
| Dec 31, 2014 | 155.30M | -35.32% |
| Dec 31, 2013 | 240.10M | -18.31% |
| Sep 25, 2013 | 293.90M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 24.85M |
| Enlivex | 24.34M |
| Senti Biosciences | 24.19M |
| Vistagen Therapeutics | 24.13M |
| Passage Bio | 23.83M |
| Lantern Pharma | 23.82M |
| Longeveron | 22.80M |
| Marker Therapeutics | 22.34M |